Compumedics Share Price and Company Fundamentals
Last traded: Today at 3:30 AM
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostic products; Nuevo LTM EEG; Orion LifeSpan MEG; and quik-cap EEG electrode arrays. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.
Key Metrics
PE ratio
-
PB ratio
3.32
Dividend yield
-
Beta
0.28
Market cap
$74.91M
Enterprise value
$83.27M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Full time employees | 175 |
| Website | https://www.compumedics.com.au |
| Mailing address | 30-40 Flockhart Street Abbotsford VIC 3067 Australia |
| Phone / Fax | 61 3 8420 7300 / 61 3 8420 7399 |
Dividends
More: Compumedics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Compumedics paid $- dividend and the ex-dividend date was 23 Nov 2004.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CMP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Compumedics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. David Burton Ph.D. | Founder, Executive Chairman & CEO | 66 | |
| Mr. David Francis Lawson | CFO, Company Secretary & Executive Director | 60 | |
| Mr. Warwick Freeman | Chief Technology Officer | ||
| Dr. Kerry Trent Hubick | Legal Counsel and Trademark, Patent & General Legal Attorney |
Profitability and management effectiveness
Profit margin
-2.48%
Operating margin
4.14%
Return on assets
1.18%
Return on equity
-6.35%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Compumedics is 74.91M and its enterprise value is 83.27M. The enterprise value to revenue ratio of CMP is 1.63. The enterprise value to EBITDA ratio of CMP is 59.52.
The CMP's stocks Beta value is 0.28 making it 72% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Compumedics (CMP)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Compumedics (ASX:CMP) Frequently Asked Questions
1. What is Compumedics's Stock Symbol?
Compumedics trades on ASX under the ticker symbol "CMP".
2. What is Compumedics's stock price today?
One share of CMP stock can currently be purchased for approximately $0.375.
3. How can I contact Compumedics?
Compumedics's mailing address is 30-40 Flockhart Street Abbotsford VIC 3067 Australia. The company can be reached via phone at 61 3 8420 7300.
4. What is Compumedics's official website?
The official website of Compumedics is https://www.compumedics.com.au.